Literature DB >> 6118408

Effects of cyclodextrins on chlorpromazine-induced haemolysis and central nervous system responses.

K Uekama, T Irie, M Sunada, M Otagiri, K Iwasaki, Y Okano, T Miyata, Y Kasé.   

Abstract

Cyclodextrins (CyDs) protected the human erythrocytes from haemolysis induced with chlorpromazine (CPZ) in isotonic solution, depending upon the magnitude of the stability constant of CPZ-CyD complexes (beta-greater than-gamma-greater than alpha-CyD). From the observations of CPZ uptake into erythrocytes and changes in surface activity of CPZ, the protective effects of CyDs in vitro appeared to be due to the decrease in effective haemolytic concentration of CPZ through inclusion complex formation rather than the direct interaction of CyDs with the erythrocyte membrane. The effect of beta-CyD on some central nervous system (c.n.s.) actions of CPZ in rats was also investigated to see if there were any advantages in the use of beta-CyD complexes given by injection. The results suggest that beta-CyD does not after the time-course or magnitude of the effects of CPZ on the c.n.s.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6118408     DOI: 10.1111/j.2042-7158.1981.tb13909.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Complexation studies of cyclodextrins with tricyclic antidepressants using ion-selective electrodes.

Authors:  G N Valsami; M A Koupparis; P E Macheras
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

2.  The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat.

Authors:  H W Frijlink; E J Franssen; A C Eissens; R Oosting; C F Lerk; D K Meijer
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

3.  An attempt to reduce the photosensitizing potential of chlorpromazine with the simultaneous use of beta- and dimethyl-beta-cyclodextrins in guinea pigs.

Authors:  T Hoshino; K Ishida; T Irie; K Uekama; T Ono
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.